IRIS
GIGLIO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 325
EU - Europa 262
AS - Asia 68
OC - Oceania 1
Totale 656
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 325
IE - Irlanda 86
SE - Svezia 66
IT - Italia 34
SG - Singapore 34
CN - Cina 31
UA - Ucraina 30
DE - Germania 25
FI - Finlandia 12
GB - Regno Unito 6
CZ - Repubblica Ceca 2
IN - India 2
AT - Austria 1
AU - Australia 1
TH - Thailandia 1
Totale 656
Salva come PNG Salva come JPEG
Città #
Dublin 86
Chandler 85
Jacksonville 60
Nyköping 36
Dearborn 29
Singapore 29
Beijing 17
Princeton 12
Cambridge 11
Medford 11
Boardman 10
Ashburn 9
Des Moines 9
Messina 9
New York 6
Wilmington 4
Hefei 3
Milan 3
Reggio Calabria 3
Woodbridge 3
Ann Arbor 2
Brno 2
Hebei 2
Nordhastedt 2
Rome 2
Washington 2
Bremen 1
Carrara 1
Hanover 1
Helsinki 1
Hyderabad 1
Jinan 1
London 1
Mesagne 1
Nanjing 1
Nanning 1
Norwalk 1
Pune 1
Seattle 1
Serra 1
Shenyang 1
Soverato Marina 1
Taizhou 1
Tappahannock 1
Vienna 1
Wuxi 1
Totale 467
Salva come PNG Salva come JPEG
Nome #
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery 73
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 69
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 59
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 54
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 52
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 52
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 49
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 48
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 46
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 43
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 41
SIMPLE MICROWAVE-ASSISTED LIGAND-FREE SUZUKI CROSS-COUPLING: FUNCTIONALIZATION OF HALO-PYRIMIDINE MOIETIES 39
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD-Manager): Study protocol for a pilot randomised controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services 33
Totale 658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202078 0 0 0 0 0 21 23 12 1 8 13 0
2020/202169 12 0 10 7 0 11 0 7 0 8 7 7
2021/202251 0 1 1 0 1 0 9 2 1 0 9 27
2022/2023255 15 27 9 27 23 24 2 18 100 1 7 2
2023/202469 1 16 4 9 10 14 1 8 2 1 0 3
2024/202547 9 1 5 24 8 0 0 0 0 0 0 0
Totale 658